237690 — ST Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for ST Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3,377	17,516	17,523	32,464	54,562
Depreciation
Amortisation
Non-Cash Items	10,100	15,604	27,646	19,656	17,669
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-20,622	-43,689	-66,898	31,750	-88,123
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	7,270	7,031	1,298	109,451	13,989
Capital Expenditures	-51,918	-60,663	-43,443	-83,224	-47,285
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	43,885	54,939	-38,945	-3,318	20,959
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-8,034	-5,724	-82,388	-86,543	-26,326
Financing Cash Flow Items	-245	462	122	-627	-764
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-116	10,808	81,401	-10,954	-20,083
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	578	10,998	-104	13,308	-32,859